Recruitment Wars: Grad Schools Battle For The Best And Brightest

In the fall of 1986, Will Talbot was just another college senior nervously applying to graduate school. He knew his credentials were good. As an ambitious high school junior in Gainesville, Fla. he had talked his way into an immunology research laboratory to begin hands-on training at the lab bench. And as a student at the University of Florida, he had compiled an outstanding academic record. But he figured that the competition for top programs in molecular biology would be stiff. “I appli

Written byMarcia Barinaga
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

In the fall of 1986, Will Talbot was just another college senior nervously applying to graduate school. He knew his credentials were good. As an ambitious high school junior in Gainesville, Fla. he had talked his way into an immunology research laboratory to begin hands-on training at the lab bench. And as a student at the University of Florida, he had compiled an outstanding academic record. But he figured that the competition for top programs in molecular biology would be stiff. “I applied to seven or eight schools,” he recalls, “hoping that I would get an offer from one, or maybe two.”

Surprise. Just a week or two after he mailed his applications, the phone began to ring. Stanford was interested. So were Harvard, MIT, Caltech, and the University of California programs at Berkeley, San Francisco, and San Diego. Suddenly, Talbot found himself flying from city to city and campus ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies